The Fat That Fights Inflammation
If there is one supplement category with genuine, broad-based scientific support in companion animal nutrition, it is marine-derived omega-3 fatty acids. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) have been studied in dogs and cats for conditions ranging from osteoarthritis and dermatological disease to cognitive decline and cardiovascular health. The evidence, while not uniformly conclusive, is more robust than for almost any other non-pharmaceutical supplement in veterinary use.
Understanding the Omega-3 Family
Not all omega-3 fatty acids are equivalent. The three most relevant to pet nutrition are:
- ALA (alpha-linolenic acid) — found in plant sources such as flaxseed, hemp seed, and chia. This is the precursor from which EPA and DHA can theoretically be synthesised.
- EPA — the primary anti-inflammatory omega-3, found in marine sources including oily fish and algae
- DHA — critical for neurological and retinal development and function, also marine-sourced
The critical caveat is that both dogs and cats convert ALA to EPA and DHA with very poor efficiency. Cats are even more limited than dogs — they have minimal delta-6-desaturase activity, the enzyme needed to initiate this conversion. For practical purposes, both species require a preformed dietary source of EPA and DHA; plant-based omega-3 from flaxseed oil does not adequately substitute for fish oil or algae oil.
What the Research Shows for Dogs
Joint Disease and Inflammation
The evidence base for EPA and DHA in canine osteoarthritis is among the strongest in pet supplement research. Multiple controlled trials have demonstrated that dogs with degenerative joint disease supplemented with fish oil at therapeutic doses show measurable improvements in lameness scores, weight-bearing, and owner-assessed mobility. A commonly referenced study published in the Journal of Veterinary Internal Medicine found that dogs with osteoarthritis fed diets enriched with EPA and DHA required lower doses of non-steroidal anti-inflammatory drugs, suggesting an additive anti-inflammatory effect.
Skin and Coat Health
Omega-3 supplementation is widely used in managing canine atopic dermatitis, seborrhoea, and pruritus. The evidence supports modest reductions in clinical scores for itching and inflammation, though omega-3s are generally considered an adjunct therapy rather than a primary treatment for allergic skin disease. They do not replace veterinary diagnosis or pharmaceutical management where that is indicated.
Cardiac Disease
EPA and DHA have been studied in dogs with cardiac disease, particularly those with DCM. Research from the Cardiac Laboratory at Tufts University found that supplementation improved cardiac cachexia markers and may support muscle preservation in dogs with heart failure. Some veterinary cardiologists now incorporate omega-3 supplementation into the management of canine cardiac disease, though always as part of a broader treatment plan.
Cognitive Function in Ageing Dogs
DHA plays a structural role in neuronal membranes, and emerging research suggests that supplementation may support cognitive function in ageing dogs. Studies in dogs with canine cognitive dysfunction syndrome have shown some benefit from DHA-enriched diets, including improvements in learning tasks and reduced disorientation behaviours, though the evidence is still developing.
What the Research Shows for Cats
Fewer large-scale trials exist for cats, but the same fundamental biochemistry applies. DHA is essential for retinal function and neurological development in kittens — this is well-established. Queen's diets supplemented with DHA during pregnancy and lactation result in kittens with measurably better visual acuity and learning performance in developmental studies.
In adult cats, omega-3 supplementation shows promise for inflammatory skin conditions and chronic kidney disease, where its ability to reduce intrarenal inflammation and slow the progression of fibrosis has attracted interest. Omega-3 supplementation in cats with CKD is used by some veterinary nephrologists, though the clinical trial data in cats is less extensive than in dogs.
Dosing and Sources
Therapeutic omega-3 dosing for dogs with specific conditions is generally higher than what most commercial pet foods provide. Published guidelines from veterinary dermatologists suggest doses in the range of 50–200 mg EPA and DHA combined per kilogram of body weight daily for inflammatory conditions, though your vet should advise on the appropriate dose for your specific animal's condition and weight.
Quality of source matters considerably:
- Fish oils from small oily fish such as sardines, anchovies, and mackerel are preferred — they are lower in the food chain and carry less risk of heavy metal accumulation
- Algae-derived DHA is a sustainable, fish-free alternative with equivalent bioavailability and is particularly valuable for animals with fish sensitivities
- Cod liver oil should not be used as a primary omega-3 source — its high vitamin A and D content can lead to toxicity at therapeutic omega-3 doses
- Look for products that provide a certificate of analysis confirming EPA and DHA content and freedom from contaminants
Adding Omega-3 to Your Pet's Diet
For most healthy dogs and cats, a moderate daily supplement from a quality source is unlikely to cause harm and may provide meaningful benefit — particularly for animals fed kibble, which tends to be low in omega-3s due to oxidation during processing. However, high-dose supplementation should always be discussed with your vet first, as omega-3 fatty acids can affect blood clotting and interact with certain medications. Store fish oils in the refrigerator once opened to prevent oxidation, and never use rancid oil — oxidised fats are pro-inflammatory rather than anti-inflammatory, which defeats the purpose entirely.